46
Growth Score in past quarter
pts
Heat Score 46 in past quarter
14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
658569
MeiraGTx Netherlands develops gene therapies using viral vectors with a focus on adeno-associated virus-based treatments.
About the Company
MeiraGTx Netherlands develops localized gene therapy using viral vector technology, with a particular emphasis on adeno-associated virus (AAV)-based treatments. The company supports the discovery and development of multiple therapeutic candidates, collaborating with scientific partners to advance their research. As part of a broader global group,
it contributes to innovations in viral vector development and precision gene regulation platforms.